Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 307,959 | 268,062 | 283,989 | 278,633 | 264,566 |
| Cost of Goods | 28,316 | 24,791 | 26,225 | 21,647 | 20,734 |
| Gross Profit | 279,643 | 243,271 | 257,764 | 256,986 | 243,832 |
| Operating Expenses | 242,123 | 248,678 | 240,598 | 221,877 | 212,192 |
| Operating Income | 37,836 | -4,616 | 17,391 | 35,756 | 32,374 |
| Other Income | 8,637 | 8,597 | 8,928 | 8,839 | 7,837 |
| Pre-tax Income | 46,473 | 3,981 | 26,319 | 44,595 | 40,211 |
| Income Tax | 14,973 | 344 | -247,249 | -27,184 | 13,545 |
| Net Income Continuous | 31,500 | 3,637 | 273,568 | 71,779 | 26,666 |
| Net Income | $31,500 | $3,637 | $273,568 | $71,779 | $26,666 |
| EPS Basic Total Ops | 0.18 | 0.02 | 1.62 | 0.43 | 0.16 |
| EPS Basic Continuous Ops | 0.18 | 0.02 | 1.62 | 0.43 | 0.16 |
| EPS Diluted Total Ops | 0.18 | 0.02 | 1.61 | 0.42 | 0.16 |
| EPS Diluted Continuous Ops | 0.18 | 0.02 | 1.61 | 0.42 | 0.16 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.02 | 0.16 | 0.26 | 0.16 |
| EBITDA(a) | $40,943 | $-2,076 | $19,645 | $37,604 | $33,773 |